
The general goal of fetal therapy is to act early enough to minimize or even prevent lasting harm from severe problems that start in the womb. With a bone-marrow transplant, the added advantage of giving it before birth is that the fetal immune system is not yet fully developed, so it is unlikely to reject the transplant. Full article (New York Times).